Header Logo

Connection

Naoko Takebe to Neurofibromin 2

This is a "connection" page, showing publications Naoko Takebe has written about Neurofibromin 2.
Connection Strength

0.247
  1. Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U. JCO Precis Oncol. 2024 Dec; 8:e2400327.
    View in: PubMed
    Score: 0.247
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.